[
1. Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 20161;6 Suppl 1:S22-209. DOI: 10.1002/alr.21695.10.1002/alr.2169526889651
]Search in Google Scholar
[
2. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. DOI: 10.4193/Rhin20.600.10.4193/Rhin20.60032077450
]Search in Google Scholar
[
3. Fokkens W, Van Der Lans R, Reitsma S. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis. Expert Opin Biol Ther. 2021;21(5):575-85. DOI: 10.1080/14712598.2021.1901881.10.1080/14712598.2021.190188133724109
]Search in Google Scholar
[
4. Chaskes MB, Kong KA, Senior B. Biologic therapy for the treatment of chronic rhinosinusitis with nasal polyposis: An update and review of the literature. Eur J Rhinol Allergy. 2021;4(3):72-6.10.5152/ejra.2021.21050
]Search in Google Scholar
[
5. Kartush AG, Schumacher JK, Shah R, Patadia MO. Biologic agents for the treatment of chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2019;33(2):203-11. DOI: 10.1177/1945892418814768.10.1177/194589241881476830587005
]Search in Google Scholar
[
6. Thamboo A, Kilty S, Witterick I, Chan Y, Chin CJ, Janjua A, et al. Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis. J of Otolaryngol – Head & Neck Surg. 2021;50(1):15. DOI: 10.1186/s40463-021-00493-2.10.1186/s40463-021-00493-2794530033750471
]Search in Google Scholar
[
7. Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, et al. EUFOREA consensus on 4biologics for CRSwNP with or without asthma. Allergy. 2019;74(2):2312-9. DOI: 10.1111/all.13875.10.1111/all.13875697298431090937
]Search in Google Scholar
[
8. Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, Solà I, et al. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines. Allergy. 2021;76(8):2337-53. DOI: 10.1111/all.14809.10.1111/all.1480933683704
]Search in Google Scholar
[
9. Bachert C, Desrosiers MY, Hellings PW, Laidlaw TM. The role of biologics in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2021;9(3):1099-106. DOI: 10.1016/j.jaip.2020.11.017.10.1016/j.jaip.2020.11.01733227522
]Search in Google Scholar
[
10. Peters AT, Han JK, Hellings P, Heffler E, Gevaert P, Bachert C, et al. Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2021;9(6):2461-2471.e5. DOI: 10.1016/j.jaip.2021.01.031.10.1016/j.jaip.2021.01.03133548517
]Search in Google Scholar
